Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?Zacks Investment Research • 07/29/26
DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement ExpansionZacks Investment Research • 07/27/26
Kaskela Law Firm Announces Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Shareholders with Investment Losses to Contact the FirmBusiness Wire • 07/23/26
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot ProgramBusiness Wire • 07/22/26
DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGMZacks Investment Research • 07/14/26
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with DiabetesBusiness Wire • 07/13/26
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern TimeBusiness Wire • 07/09/26
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?Zacks Investment Research • 06/26/26
DexCom to Roll Out Reimagined Stelo App With Global Expansion PlansZacks Investment Research • 06/24/26
DXCM Receives FDA Clearance for Stelo OTC CGM System for ChildrenZacks Investment Research • 06/16/26
Pharmsource says it was unaware Dexcom sensors it bought were slated for destructionReuters • 06/11/26
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in studyReuters • 06/06/26